TEL AVIV, Israel, Sept. 22, 2022 /PRNewswire/ -- Ellomay Capital Ltd.(NYSE American: ELLO) (TASE: ELLO)("Ellomay" or the "Company"), a renewable energy and power generator and developer of renewable energy and power projects in Europe and Israel, today reported unaudited financial results for the three month period ended June 30, 2022.
Financial Highlights
CEO Review Second Quarter 2022
In the first half and the second quarter of 2022, the Company met the goals it set for itself. Compared to the corresponding period last year, the Company recorded an increase of approximately 43% in its revenues, which were higher than the projected revenues for the period. The cash flow from operations for the first half of 2022 was approximately €8 million, after deduction of a non-recurring advance payment of income tax as per a tax assessment agreement (timing differences of payable income tax) to the Israeli Tax Authority in connection with the Talmei Yosef PV Plant in the amount of approximately €3.2 million.
The profit for the second quarter of 2022 almost doubled compared to the corresponding period last year, and the net profit for the quarter was approximately €2.8 million, compared to a loss of approximately €2.5 million in the corresponding quarter last year.
Based on the preliminary results of the third quarter of 2022 currently available to the Company, it is expected that the Company will meet the goals it set for itself for the first nine months of 2022.
The Company operates on two main levels: the development of a backlog of projects in the PV field in Italy, Spain and Israel, and the construction and operation of projects. Currently, a pumped hydro storage project in the Manara Cliff in Israel, which is a mega project in scope, is under construction. In addition, 20 MV PV plants are also under advanced construction in Italy.
Activity in Spain: The Ellomay Solar project (28 MW PV) was connected to the electricity grid towards the end of the second quarter of 2022, therefore its effect on the quarter was negligible. During the third quarter of 2022 this PV plant operated at full capacity and the expected revenues from it for the third quarter of 2022 are approximately €2.5-3 million. The Talasol PV plant (300 MW PV), 51% held by the Company, met all expectations and in the first half of 2022 generated revenues in the amount of approximately €20.4 million.
Activity in Italy: The Company has approximately 600 MW PV projects under advanced development stages, of which licenses have been obtained for approximately 200 MW. Of these 200 MW PV projects, 20 MW are under advanced construction and the remainder (approximately 180 MW) are awaiting the results of a contractor tender which is expected to be finalized at the end of September 2022. The construction agreements are expected to be signed following the decision with respect to the contractor, and construction work will commence thereafter.
The Company has additional projects in earlier development stages and the intention is to reach a portfolio of approximately 1,000 MW PV in various degrees of development and operations by the year 2025.
The Company is negotiating a financing agreement for the financing of 600 MW PV projects that are in advanced development stages with a leading European bank in the field.
Activity in Israel: The Company is engaged in the construction and management of the Manara Cliff pumped storage project, which is in advanced construction.
The development of the licenses for the construction of 40 MW PV + 80 MW/hour storage in batteries is in advanced stages. A connection to the electricity grid was guaranteed for a large part of the project, the tender for contractors was concluded and a winning contractor was selected. The Company is in negotiations with financing entities for the purpose of obtaining financing for the project.
The Company continues to develop a portfolio of land for future projects in the field of PV and battery storage, including the potential expansion of the Talmei Yosef project.
Activity in the Netherlands: In connection with the war in Ukraine and the stoppage of Russian gas supply to Europe, there are substantial changes in the field of biogas in the Netherlands and Europe. Europe in general and the Netherlands specifically have set ambitious goals for increasing gas production from waste. Various incentives are being considered, the main of which is pushing the price of the green certificates upwards and as of today the price of the aforementioned certificates has increased from 13–15-euro cents per certificate to around 45-euro cents per certificate. The gas price for 2023, which is determined on the basis of the 2022 average, is also expected to be above 90-euro cents per cubic meter, a price that is higher than the cap of the subsidy (75-euro cents per cubic meter). Therefore, in 2023 and possibly also in 2024 the Company will examine the possibility of temporarily exiting the subsidy regime. Not using the subsidy during 2023 and 2024 will enable the Company to postpone the termination of the subsidy period (originally 12 years) by two years.
Green certificates are issued according to the amount of green gas supplied by the Company's plants, whereby for every cubic meter supplied, the Company receives one green certificate. The Company currently expects to produce approximately 14 million cubic meters of green gas during 2023, which are expected to be sold at an average price of 45 Eurocents per certificate. The expected income to the Company is therefore approximately €6 million for 2023, compared to an average income from the sale of green certificates of approximately €2 million in previous years.
On the other hand, due to the war in Ukraine, there was an increase in the price of feedstock, which is based on agricultural residues, and in the cost of transportation and the price of electricity (which increased tenfold). These circumstances caused an increase in expenses, however the Company expects that the increase in income will exceed the increase in expenses. The increase in income is already partially reflected in the high prices of the green certificates and is expected to continue to be reflected next year as prices of green certificates are expected to continue to increase, and in addition gas prices are also expected to be high.
The increase in electricity prices in the Netherlands did not substantially affect 2 of the 3 biogas facilities owned by the Company, which produce the electricity and heat they consume for themselves. However, the Gelderland project, which was acquired in December 2020, is not equipped with the means to self-generate electricity and heat and is required to pay for the electricity, and therefore was negatively affected by the increase in the price of electricity. In May 2022, the Company received notification of approval for a subsidy for generation of electricity and heat in Gelderland and, in August 2022, a generator (CHP) was ordered and is expected to start producing electricity for the Gelderland facility this December or January.
The Company estimates that with the increasing importance of the biogas field, this field will enter a new period which is expected to substantially improve the results of the Company's biogas facilities.
Use of NON-IFRS Financial Measures
EBITDA is a non-IFRS measure and is defined as earnings before financial expenses, net, taxes, depreciation and amortization. The Company presents this measure in order to enhance the understanding of the Company's operating performance and to enable comparability between periods. While the Company considers EBITDA to be an important measure of comparative operating performance, EBITDA should not be considered in isolation or as a substitute for net income or other statement of operations or cash flow data prepared in accordance with IFRS as a measure of profitability or liquidity. EBITDA does not take into account the Company's commitments, including capital expenditures and restricted cash and, accordingly, is not necessarily indicative of amounts that may be available for discretionary uses. Not all companies calculate EBITDA in the same manner, and the measure as presented may not be comparable to similarly-titled measure presented by other companies. The Company's EBITDA may not be indicative of the Company's historic operating results; nor is it meant to be predictive of potential future results. The Company uses this measure internally as performance measure and believes that when this measure is combined with IFRS measure it add useful information concerning the Company's operating performance. A reconciliation between results on an IFRS and non-IFRS basis is provided on page 12 of this press release.
About Ellomay Capital Ltd.
Ellomay is an Israeli based company whose shares are registered with the NYSE American and with the Tel Aviv Stock Exchange under the trading symbol "ELLO". Since 2009, Ellomay Capital focuses its business in the renewable energy and power sectors in Europe and Israel.
To date, Ellomay has evaluated numerous opportunities and invested significant funds in the renewable, clean energy and natural resources industries in Israel, Italy and Spain, including:
For more information about Ellomay, visit http://www.ellomay.com.
Information Relating to Forward-Looking Statements
This press release contains forward-looking statements that involve substantial risks and uncertainties, including statements that are based on the current expectations and assumptions of the Company's management. All statements, other than statements of historical facts, included in this press release regarding the Company's plans and objectives, expectations and assumptions of management are forward-looking statements. The use of certain words, including the words "estimate," "project," "intend," "expect," "believe" and similar expressions are intended to identify forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. The Company may not actually achieve the plans, intentions or expectations disclosed in the forward-looking statements and you should not place undue reliance on the Company's forward-looking statements. Various important factors could cause actual results or events to differ materially from those that may be expressed or implied by the Company's forward-looking statements, including the impact of continued war between Russia and Ukraine, including its impact on electricity prices, availability of raw materials and disruptions in supply changes, the impact of the Covid-19 pandemic on the Company's operations and projects, including in connection with steps taken by authorities in countries in which the Company operates, changes in the market price of electricity and in demand, regulatory changes, including extension of current or approval of new rules and regulations increasing the operating expenses of manufacturers of renewable energy in Spain, increases in interest rates and inflation, changes in the supply and prices of resources required for the operation of the Company's facilities (such as waste and natural gas) and in the price of oil, and technical and other disruptions in the operations or construction of the power plants owned by the Company. These and other risks and uncertainties associated with the Company's business are described in greater detail in the filings the Company makes from time to time with Securities and Exchange Commission, including its Annual Report on Form 20-F. The forward-looking statements are made as of this date and the Company does not undertake any obligation to update any forward-looking statements, whether as a result of new information, future events or otherwise.
Contact:Kalia Rubenbach (Weintraub)CFOTel: +972 (3) 797-1111Email: hilai@ellomay.com
Ellomay Capital Ltd. and its Subsidiaries | |||
Condensed Consolidated Interim Statements of Financial Position | |||
June 30, | December 31, | June 30, | |
2022 | 2021 | 2022 | |
(Unaudited) | (Audited) | (Unaudited) | |
€ in thousands | Convenience Translation into US$ in thousands* | ||
Assets | |||
Current assets: | |||
Cash and cash equivalents | 59,951 | 41,229 | 62,287 |
Marketable securities | 1,761 | 1,946 | 1,830 |
Short term deposits | - | 28,410 | - |
Restricted cash | 4,280 | 1,000 | 4,447 |
Receivable from concession project | 1,786 | 1,784 | 1,856 |
Trade and other receivables | 10,744 | 9,487 | 11,163 |
78,522 | 83,856 | 81,583 | |
Non-current assets | |||
Investment in equity accounted investee | 32,410 | 34,029 | 33,673 |
Advances on account of investments | 1,554 | 1,554 | 1,615 |
Receivable from concession project | 25,991 | 26,909 | 27,004 |
Fixed assets | 352,680 | 340,897 | 366,424 |
Right-of-use asset | 23,360 | 23,367 | 24,270 |
Intangible asset | 4,418 | 4,762 | 4,590 |
Restricted cash and deposits | 20,379 | 15,630 | 21,174 |
Deferred tax | 23,723 | 12,952 | 24,648 |
Long term receivables | 8,581 | 5,388 | 8,915 |
Derivatives | 2,718 | 2,635 | 2,824 |
495,814 | 468,123 | 515,137 | |
Total assets | 574,336 | 551,979 | 596,720 |
Liabilities and Equity | |||
Current liabilities | |||
Current maturities of long-term bank loans | 12,306 | 126,180 | 12,786 |
Current maturities of long-term loans | 10,000 | 16,401 | 10,390 |
Current maturities of debentures | 19,785 | 19,806 | 20,556 |
Trade payables | 2,059 | 2,904 | 2,138 |
Other payables | 20,120 | 20,806 | 20,904 |
Current maturities of derivatives | 38,996 | 14,783 | 40,516 |
Current maturities of lease liabilities | 675 | 4,329 | 701 |
103,941 | 205,209 | 107,991 | |
Non-current liabilities | |||
Long-term lease liabilities | 16,206 | 15,800 | 16,838 |
Long-term loans | 217,845 | 39,093 | 226,335 |
Other long-term bank loans | 25,754 | 37,221 | 26,758 |
Debentures | 93,973 | 117,493 | 97,635 |
Deferred tax | 6,409 | 9,044 | 6,659 |
Other long-term liabilities | 3,324 | 3,905 | 3,454 |
Derivatives | 24,198 | 10,107 | 25,141 |
387,709 | 232,663 | 402,820 | |
Total liabilities | 491,650 | 437,872 | 510,811 |
Equity | |||
Share capital | 25,605 | 25,605 | 26,603 |
Share premium | 85,943 | 85,883 | 89,292 |
Treasury shares | (1,736) | (1,736) | (1,804) |
Transaction reserve with non-controlling Interests | 5,697 | 5,697 | 5,919 |
Reserves | (11,763) | 7,288 | (12,221) |
Accumulated deficit | (8,121) | (6,899) | (8,437) |
Total equity attributed to shareholders ofthe Company | 95,625 | 115,838 | 99,352 |
Non-Controlling Interest | (12,939) | (1,731) | (13,443) |
Total equity | 82,686 | 114,107 | 85,909 |
Total liabilities and equity | 574,336 | 551,979 | 596,720 |
* Convenience translation into US$ (exchange rate as at June 30, 2022: euro 1 = US$ 1.039) |
Ellomay Capital Ltd. and its Subsidiaries | ||||||
Condensed Consolidated Interim Statements of Profit or Loss and Other Comprehensive Income or Loss | ||||||
For the Three months ended June 30, | For the Six months ended June 30, | For the year ended December 31, | For the six months ended June 30, | |||
2022 | 2021 | 2022 | 2021 | 2021 | 2022 | |
Unaudited | Unaudited | Audited | Unaudited | |||
€ in thousands |
€ in thousands |
€ in thousands |
Convenience Translation into US$ in thousands* | |||
Revenues | 17,435 | 13,193 | 29,196 | 20,393 | 45,721 | 30,334 |
Operating expenses | (7,161) | (4,355) | (13,132) | (7,572) | (17,590) | (13,644) |
Depreciation and amortization expenses | (3,964) | (4,025) | (7,978) | (7,076) | (15,116) | (8,289) |
Gross profit | 6,310 | 4,813 | 8,086 | 5,745 | 13,015 | 8,401 |
Project development costs | (843) | (614) | (1,554) | (1,119) | (2,508) | (1,615) |
General and administrative expenses | (1,820) | (1,309) | (3,297) | (2,572) | (5,661) | (3,425) |
Share of profits of equity accounted investee | (833) | (1,389) | (602) | (772) | 117 | (625) |
Operating profit | 2,814 | 1,501 | 2,633 | 1,282 | 4,963 | 2,736 |
Financing income | 3,630 | 850 | 4,439 | 1,716 | 2,931 | 4,612 |
Financing income (expenses) in connection with derivatives and warrants, net | 372 | 15 | 338 | (109) |
(841) | 351 |
Financing expenses in connection with projects finance | (2,524) | (2,193) | (3,889) | (3,658) | (17,800) | (4,041) |
Financing expenses in connection with debentures | (314) | (788) | (1,343) | (2,764) | (3,220) | (1,395) |
Interest expenses on minority shareholder loan | (349) | (557) | (892) | (939) | (2,055) | (927) |
Other financing expenses | (50) | (699) | (834) | (384) | (5,899) | (867) |
Financing income (expenses), net | 765 | (3,372) | (2,181) | (6,138) | (26,884) | (2,267) |
Profit (loss) before taxes on income | 3,579 | (1,871) | 452 | (4,856) | (21,921) | 469 |
Tax benefit (Taxes on income) | (808) | (625) | (1,087) | (306) | 2,281 | (1,129) |
Profit (loss) for the period | 2,771 | (2,496) | (635) | (5,162) | (19,640) | (660) |
Profit (loss) attributable to: | ||||||
Owners of the Company | 1,712 | (3,183) | (1,222) | (5,252) | (15,090) | (1,270) |
Non-controlling interests | 1,059 | 687 | 587 | 90 | (4,550) | 610 |
Profit (loss) for the period | 2,771 | (2,496) | (635) | (5,162) | (19,640) | (660) |
Other comprehensive income (loss) item | ||||||
that after initial recognition in comprehensive income (loss) were or will be transferred to profit or loss: | ||||||
Foreign currency translation differences for foreign operations | (3,585) | 1,122 | (3,683) | 1,684 | 12,284 | (3,826) |
Effective portion of change in fair value of cash flow hedges | 8,844 | (3,273) | (31,942) | (5,202) | (13,429) | (33,186) |
Net change in fair value of cash flow hedges transferred to profit or loss | 794 | (221) | 821 | (1,225) | (3,353) | 853 |
Total other comprehensive income (loss) | 6,053 | (2,372) | (34,804) | (4,743) | (4,498) | (36,159) |
Total other comprehensive income (loss) attributable to: | ||||||
Owners of the Company | 1,618 | (652) | (19,051) | (1,764) | 3,124 | (19,793) |
Non-controlling interests | 4,435 | (1,720) | (15,753) | (2,979) | (7,622) | (16,366) |
Total other comprehensive income (loss) for the period | 6,053 | (2,372) | (34,804) | (4,743) | (4,498) | (36,159) |
Total comprehensive income (loss) for the period | 8,824 | (4,868) | (35,439) | (9,905) | (24,138) | (36,819) |
Total comprehensive income (loss) attributable to: | ||||||
Owners of the Company | 3,330 | (3,835) | (20,273) | (7,016) | (11,966) | (21,063) |
Non-controlling interests | 5,494 | (1,033) | (15,166) | (2,889) | (12,172) | (15,756) |
Total comprehensive income (loss) for the period | 8,824 | (4,868) | (35,439) | (9,905) | (24,138) | (36,819) |
Basic net earnings (loss) per share | 0.13 | (0.25) | (0.10) | (0.41) | (1.18) | (0.10) |
Diluted net earnings (loss) per share | 0.13 | (0.25) | (0.10) | (0.41) | (1.18) | (0.10) |
Ellomay Capital Ltd. and its Subsidiaries | ||||||||||
Condensed Consolidated Statements of Changes in Equity | ||||||||||
Attributable to shareholders of the Company | Non- controlling | Total | ||||||||
Interests | Equity | |||||||||
Share capital |
Share premium |
Accumulated Deficit |
Treasury shares |
Translation reserve from foreign operations |
Hedging Reserve | Interests Transaction reserve with non-controlling Interests |
Total | |||
€ in thousands | ||||||||||
For the six months ended | ||||||||||
June 30, 2022 (Unaudited): | ||||||||||
Balance as at January 1, 2022 | 25,605 | 85,883 | (6,899) | (1,736) | 15,365 | (8,077) | 5,697 | 115,838 | (1,731) | 114,107 |
Profit (loss) for the period | - | - | (1,222) | - | - | - | - | (1,222) | 587 | (635) |
Other comprehensive loss for the period | - | - | - | - | (3,466) | (15,585) | - | (19,051) | (15,753) | (34,804) |
Total comprehensive loss for the period | - | - | (1,222) | - | (3,466) | (15,585) | - | (20,273) | (15,166) | (35,439) |
Transactions with owners of the Company, recognized directly in equity: | ||||||||||
Issuance of Capital note to non-controlling interest | - | - | - | - | - | - | - | - | 3,958 | 3,958 |
Share-based payments | - | 60 | - | - | - | - | - | 60 | - | 60 |
Balance as at June 30, 2022 | 25,605 | 85,943 | (8,121) | (1,736) | 11,899 | (23,662) | 5,697 | 95,625 | (12,939) | 82,686 |
For the six months ended | ||||||||||
June 30, 2021 (Unaudited): | ||||||||||
Balance as at January 1, 2021 | 25,102 | 82,401 | 8,191 | (1,736) | 3,823 | 341 | 6,106 | 124,228 | 798 | 125,026 |
Profit (loss) for the period | - | - | (5,252) | - | - | - | - | (5,252) | 90 | (5,162) |
Other comprehensive income (loss) for the period | - | - | - | - | 1,636 | (3,400) | - | (1,764) | (2,979) | (4,743) |
Total comprehensive income (loss) for the period | - | - | (5,252) | - | 1,636 | (3,400) | - | (7,016) | (2,889) | (9,905) |
Transactions with owners of the Company, recognized directly in equity: | ||||||||||
Issuance of Capital note to non-controlling interest | - | - | - | - | - | - | - | - | 8,682 | 8,682 |
Acquisition of shares in subsidiaries from non-controlling interests | - | - | - | - | - | - | (961) | (961) | 961 | - |
Warrants exercise | 454 | 3,348 | - | - | - | - | - | 3,802 | - | 3,802 |
Options exercise | 22 | - | - | - | - | - | - | 22 | - | 22 |
Share-based payments | - | 13 | - | - | - | - | - | 13 | - | 13 |
Balance as at June 30, 2021 | 25,578 | 85,762 | 2,939 | (1,736) | 5,459 | (3,059) | 5,145 | 120,088 | 7,552 | 127,640 |
Ellomay Capital Ltd. and its Subsidiaries | ||||||||||
Condensed Consolidated Interim Statements of Changes in Equity (cont'd) | ||||||||||
Attributable to shareholders of the Company | Non- controlling | Total | ||||||||
Interests | Equity | |||||||||
Share capital |
Share premium |
Accumulated Deficit |
Treasury shares |
Translation reserve from foreign operations |
Hedging Reserve | Interests Transaction reserve with non-controlling Interests |
Total | |||
€ in thousands | ||||||||||
For the year ended | ||||||||||
December 31, 2021 (Audited): | ||||||||||
Balance as at January 1, 2021 | 25,102 | 82,401 | 8,191 | (1,736) | 3,823 | 341 | 6,106 | 124,228 | 798 | 125,026 |
Profit (loss) for the year | - | - | (15,090) | - | - | - | - | (15,090) | (4,550) | (19,640) |
Other comprehensive income (loss) for the year | - | - | - | - | 11,542 | (8,418) | - | 3,124 | (7,622) | (4,498) |
Total comprehensive income (loss) for the year | - | - | (15,090) | - | 11,542 | (8,418) | - | (11,966) | (12,172) | (24,138) |
Transactions with owners of the Company, recognized directly in equity: | ||||||||||
Issuance of Capital note to non-controlling interest | - | - | - | - | - | - | - | - | 8,682 | 8,682 |
Acquisition of shares in subsidiaries from non-controlling interests | - | - | - | - | - | - | (409) | (409) | 961 | 552 |
Warrants exercise | 454 | 3,419 | - | - | - | - | - | 3,873 | - | 3,873 |
Options exercise | 49 | - | - | - | - | - | - | 49 | - | 49 |
Share-based payments | - | 63 | - | - | - | - | - | 63 | - | 63 |
Balance as at December 31, 2021 | 25,605 | 85,883 | (6,899) | (1,736) | 15,365 | (8,077) | 5,697 | 115,838 | (1,731) | 114,107 |
Ellomay Capital Ltd. and its Subsidiaries | ||||||||||
Condensed Consolidated Interim Statements of Changes in Equity (cont'd) | ||||||||||
Attributable to shareholders of the Company | Non- controlling | Total | ||||||||
Interests | Equity | |||||||||
Share capital |
Share premium |
Retained earnings |
Treasury shares |
Translation reserve from foreign operations |
Hedging Reserve | Interests Transaction reserve with non-controlling Interests |
Total | |||
Convenience translation into US$ (exchange rate as at June 30, 2022: euro 1 = US$ 1.039) | ||||||||||
For the six month ended June 30, 2022 (unaudited): | ||||||||||
Balance as at January 1, 2022 | 26,603 | 89,230 | (7,167) | (1,804) | 15,964 | (8,392) | 5,919 | 120,353 | (1,799) | 118,554 |
Profit (loss) for the period | - | - | (1,270) | - | - | - | - | (1,270) | 610 | (660) |
Other comprehensive loss for the period | - | - | - | - | (3,601) | (16,192) | - | (19,793) | (16,366) | (36,159) |
Total comprehensive loss for the period | - | - | (1,270) | - | (3,601) | (16,192) | - | (21,063) | (15,756) | (36,819) |
Transactions with owners of the Company, recognizeddirectly in equity: | ||||||||||
Issuance of Capital note to non-controlling interest | - | - | - | - | - | - | - | - | 4,112 | 4,112 |
Share-based payments | - | 62 | - | - | - | - | - | 62 | - | 62 |
Balance as at June 30, 2022 | 26,603 | 89,292 | (8,437) | (1,804) | 12,363 | (24,584) | 5,919 | 99,352 | (13,443) | 85,909 |
Ellomay Capital Ltd. and its Subsidiaries | ||||||
Condensed Consolidated Interim Statements of Cash Flow | ||||||
For the three months ended June 30, | For the six months ended June 30, | For the year ended December 31, | For the six months ended June 30 | |||
2022 | 2021 | 2022 | 2021 | 2021 | 2022 | |
Unaudited | Unaudited | Audited | Unaudited | |||
€ in thousands | Convenience Translation into US$* | |||||
Cash flows from operating activities | ||||||
Loss for the period | 2,771 | (2,496) | (635) | (5,162) | (19,640) | (660) |
Adjustments for: | ||||||
Financing expenses, net | (765) | 3,372 | 2,181 | 6,138 | 26,884 | 2,267 |
Profit from settlement of derivatives contract | - | - | - | (407) | (407) | - |
Depreciation and amortization | 3,964 | 4,025 | 7,978 | 7,076 | 15,116 | 8,289 |
Share-based payment transactions | 60 | 6 | 60 | 13 | 63 | 62 |
Share of losses (profits) of equity accounted investees | 833 | 1,389 | 602 | 772 | (117) | 625 |
Payment of interest on loan by an equity accounted investee | - | 859 |
- | 859 | 859 |
- |
Change in trade receivables and other receivables | 235 | (942) | (2,579) | (2,124) | (1,883) | (2,680) |
Change in other assets | (1,788) | (812) | 53 | (782) | (545) | 55 |
Change in receivables from concessions project | (802) | 536 | (550) | 757 | 1,580 | (571) |
Changein trade payables | (726) | (559) | (801) | (941) | 154 | (832) |
Change in other payables | 2,604 | 2,119 | 7,878 | 3,715 | 2,380 | 8,185 |
Income tax expense (tax benefit) | 808 | 625 | 1,087 | 306 | (2,281) | 1,129 |
Income taxes paid | (3,255) | (15) | (3,255) | (15) | (94) | (3,382) |
Interest received | 451 | 494 | 922 | 921 | 1,844 | 958 |
Interest paid | (4,520) | (2,651) | (4,924) | (3,857) | (7,801) | (5,116) |
Net cash provided by (used in) operating activities | (130) | 5,950 | 8,017 | 7,269 | 16,112 | 8,329 |
Cash flows from investing activities | ||||||
Acquisition of fixed assets | (6,747) | (39,012) | (22,274) | (64,665) | (83,682) | (23,142) |
VAT associated with the acquisition | 2,225 | - | - | - | - | - |
Repayment of loan by an equity accounted investee | 149 | 1,400 | 149 | 1,400 | 1,400 | 155 |
Loan to an equity accounted investee | - | (131) | - | (244) | (335) | - |
Advances on account of investments | - | (8) | - | (8) | - | - |
Settlement of derivatives contract | - | - | (528) | (252) | (976) | (549) |
Proceeds (investment) in restricted cash, net | (9,344) | (639) | (8,241) | (185) | (5,990) | (8,562) |
Proceeds (investment) in short term deposit | 27,645 | - | 27,645 | 8,533 | (18,599) | 28,722 |
Proceeds from marketable securities | - | - | - | 1,785 | (112) | - |
Net cash provided by (used in) investing activities | 13,928 | (38,390) | (3,249) | (53,636) | (108,294) | (3,376) |
Cash flows from financing activities | ||||||
Sale of shares in subsidiaries to non-controlling interests | - | - | - | 1,400 | 1,400 | - |
Proceeds from options | - | - | - | 22 | 49 | - |
Cost associated with long term loans | (498) | - | (8,958) | (197) | (2,796) | (9,307) |
Payment of principal of lease liabilities | (205) | - | (4,000) | - | (4,803) | (4,156) |
Proceeds from long term loans | (331) | 5,415 | 196,189 | 32,476 | 32,947 | 203,835 |
Repayment of long-term loans | (21,723) | (2,933) | (143,095) | (3,390) | (18,905) | (148,672) |
Repayment of Debentures | (19,764) | (8,853) | (19,764) | (30,730) | (30,730) | (20,534) |
Repayment of SWAP instrument associated with long term loans | - | - |
(3,290) |
- |
- |
(3,418) |
Proceeds from issue of convertible debentures | - | - | - | 15,571 | 15,571 | - |
Proceeds from issuance of Debentures, net | - | - | - | 25,465 | 57,717 | - |
Issuance / exercise of warrants | - | - | - | 3,675 | 3,746 | - |
Net cash provided by (used in) financing activities | (42,521) | (6,371) | 17,082 | 44,292 | 54,196 | 17,748 |
Effect of exchange rate fluctuations on cash and cash equivalents | (2,307) | 1,050 | (3,128) | 2,489 | 12,370 | (3,250) |
Increase (decrease) in cash and cash equivalents | (31,030) | (37,761) | 18,722 | 414 | (25,616) | 19,451 |
Cash and cash equivalents at the beginning of the period | 90,981 | 105,020 | 41,229 | 66,845 | 66,845 | 42,836 |
Cash and cash equivalents at the end of the period
| 59,951 | 67,259 | 59,951 | 67,259 | 41,229 | 62,287 |
* Convenience translation into US$ (exchange rate as at June 30, 2022: euro 1 = US$ 1.039) |
Ellomay Capital Ltd. and its Subsidiaries | |||||||||||
Operating Segments | |||||||||||
PV | Total | ||||||||||
Ellomay | Bio | reportable | Total | ||||||||
Italy | Spain | Solar1 | Talasol | Israel2 | Gas | Dorad | Manara | segments | Reconciliations | consolidated | |
For the six months ended June 30, 2022 | |||||||||||
€ in thousands | |||||||||||
Revenues | - | 2,081 | 327 | 20,402 | 2,246 | 5,830 | 26,756 | - | 57,642 | (28,446) | 29,196 |
Operating expenses | - | (100) | (191) | (7,088) | (214) | (5,539) | (20,769) | - | (33,901) | 20,769 | (13,132) |
Depreciation expenses | - | (452) | - | (5,655) | (1,268) | (1,607) | (3,240) | - | (12,222) | 4,244 | (7,978) |
Gross profit (loss) | - | 1,529 | 136 | 7,659 | 764 | (1,316) | 2,747 | - | 11,519 | (3,433) | 8,086 |
Project development costs | (1,554) | ||||||||||
General and | |||||||||||
administrative expenses | (3,297) | ||||||||||
Share of loss of equity | |||||||||||
accounted investee | (602) | ||||||||||
Operating profit | 2,633 | ||||||||||
Financing income | 4,439 | ||||||||||
Financing expenses in connection with derivativesand warrants, net | 338 | ||||||||||
Financing expenses in connection with projects finance | (3,889) | ||||||||||
Financing expenses in connection with debentures | (1,343) | ||||||||||
Interest expenses on minority shareholder loan | (892) | ||||||||||
Other financing expenses | (834) | ||||||||||
Financing expenses, net | (2,181) | ||||||||||
Income before taxes on Income | 452 | ||||||||||
Segment assets as at June 30, 2022 | 7,273 | 15,376 | 21,684 | 267,090 | 36,404 | 31,661 | 108,718 | 120,906 | 609,112 | (34,776) | 574,336 |
Ellomay Capital Ltd. and its Subsidiaries | ||||||
Reconciliation of Profit (Loss) to EBITDA | ||||||
For the three months ended June 30, | For the six months ended June 30, | For the year ended December 31, | For the six months ended June 30, | |||
2022 | 2021 | 2022 | 2021 | 2021 | 2022 | |
Unaudited | ||||||
€ in thousands | Convenience Translation into US$ in thousands* | |||||
Net profit (loss) for the period | 2,771 | (2,496) | (635) | (5,162) | (19,640) | (660) |
Financing (income) expenses, net |
(765) |
3,372 |
2,181 |
6,138 | 26,884 |
2,267 |
Taxes on income (Tax benefit) |
808 |
625 |
1,087 |
306 | (2,281) |
1,129 |
Depreciation | 3,964 | 4,025 | 7,978 | 7,076 | 15,116 | 8,289 |
EBITDA | 6,778 | 5,526 | 10,611 | 8,358 | 20,079 | 11,025 |
* Convenience translation into US$ (exchange rate as at June 30, 2022: euro 1 = US$ 1.039) |
Ellomay Capital Ltd.
Information for the Company's Debenture Holders
Pursuant to the Deeds of Trust governing the Company's Series C and Series D Debentures (together, the "Debentures"), the Company is required to maintain certain financial covenants. For more information, see Item 5.B of the Company's Annual Report on Form 20-F submitted to the Securities and Exchange Commission on March 31, 2022, and below.
Net Financial Debt
As of June 30, 2022, the Company's Net Financial Debt, (as such term is defined in the Deeds of Trust of the Company's Debentures), was approximately €53.8 million (consisting of approximately €269.83 million of short-term and long-term debt from banks and other interest bearing financial obligations, approximately €115.54 million in connection with the Series C Debentures issuances (in July 2019, October 2020, February 2021 and October 2021) and Series D Debentures issuance (in February 2021), net of approximately €61.7 million of cash and cash equivalents, short-term deposits and marketable securities and net of approximately €269.85 million of project finance and related hedging transactions of the Company's subsidiaries).
Information for the Company's Series C Debenture Holders.
The Deed of Trust governing the Company's Series C Debentures (as amended on June 6, 2022, the "Series C Deed of Trust"), includes an undertaking by the Company to maintain certain financial covenants, whereby a breach of such financial covenants for two consecutive quarters is a cause for immediate repayment. As of June 30, 2022, the Company was in compliance with the financial covenants set forth in the Series C Deed of Trust as follows: (i) the Company's Adjusted Shareholders' Equity (as defined in the Series C Deed of Trust) was approximately €130.1 million, (ii) the ratio of the Company's Net Financial Debt (as set forth above) to the Company's CAP, Net (defined as the Company's Adjusted Shareholders' Equity plus the Net Financial Debt) was 29.3%, and (iii) the ratio of the Company's Net Financial Debt to the Company's Adjusted EBITDA6, was 2.1.
The following is a reconciliation between the Company's loss and the Adjusted EBITDA (as defined in the Series C Deed of Trust) for the four-quarter period ended June 30, 2022:
For the four-quarter period ended June 30, 2022 | |
Unaudited | |
€ in thousands | |
Loss for the period | (15,098) |
Financing expenses, net | 22,927 |
Taxes on income | (1,495) |
Depreciation | 15,998 |
Adjustment to revenues of the Talmei Yosef PV Plant due to calculation based on the fixed asset model | 3,389 |
Share-based payments | 110 |
Adjusted EBITDA as defined the Series C Deed of Trust | 25,831 |
Information for the Company's Series D Debenture Holders
The Deed of Trust governing the Company's Series D Debentures includes an undertaking by the Company to maintain certain financial covenants, whereby a breach of such financial covenants for the periods set forth in the Series D Deed of Trust is a cause for immediate repayment. As of June 30, 2022, the Company was in compliance with the financial covenants set forth in the Series D Deed of Trust as follows: (i) the Company's Adjusted Shareholders' Equity (as defined in the Series D Deed of Trust) was approximately €130.1 million, (ii) the ratio of the Company's Net Financial Debt (as set forth above) to the Company's CAP, Net (defined as the Company's Adjusted Shareholders' Equity plus the Net Financial Debt) was 29.3%, and (iii) the ratio of the Company's Net Financial Debt to the Company's Adjusted EBITDA7 was 2.1.
The following is a reconciliation between the Company's loss and the Adjusted EBITDA (as defined in the Series D Deed of Trust) for the four-quarter period ended June 30, 2022:
For the four-quarter period ended June 30, 2022 | |
Unaudited | |
€ in thousands | |
Loss for the period | (15,098) |
Financing expenses, net | 22,927 |
Taxes on income | (1,495) |
Depreciation | 15,998 |
Adjustment to revenues of the Talmei Yosef PV Plant due to calculation based on the fixed asset model | 3,389 |
Share-based payments | 110 |
Adjusted EBITDA as defined the Series D Deed of Trust | 25,831 |
View original content:https://www.prnewswire.com/news-releases/ellomay-capital-reports-results-for-the-three-and-six-months-ended-june-30-2022-301630812.html
SOURCE Ellomay Capital Ltd